GAPDH and Parkinson disease: Detection, quantification, and validation data were obtained by SDS-PAGE (Supplementary Figure S1) and LC-MS/MS analysis (Figure 1, Table 1) and through the ELISA test (Figure 2), respectively, demonstrating a significant overexpression of salivary GAPDH in PD patients compared to periodontally healthy control subjects.